A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. (Q39371837)
scientific article
Language:
Current Data About A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
(P31) (Q13442814)
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P304) 115-123
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P478) 100
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P577) Saturday, January 1, 2005
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P921) (Q40878)

(Q416463)
(P887)

(P1433) (Q7713501)
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P1476) "A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS." (language: en)
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P2093) Lin Chang
(P1545) 1
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

Vanessa Z Ameen
(P1545) 2
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

George E Dukes
(P1545) 3
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

David J McSorley
(P1545) 4
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

Eric G Carter
(P1545) 5
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

Emeran A Mayer
(P1545) 6
(P248)
(P698) 15654790
(P813) Monday, September 11, 2017

(P2860) (Q35010302)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q48281142)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q33701295)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q40865293)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q34532550)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q33896354)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q39436676)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q39416131)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q32054460)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q33701309)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q43746131)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q50862970)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q44165125)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q35803732)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q44963267)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q33960506)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

(Q39397861)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.40365.X
(P813) Sunday, January 21, 2018

other details
description scientific article

External Links
(P356) 10.1111/J.1572-0241.2005.40365.X
(P698) 15654790
(P5875) 8076259